Notes - Segment Information

SANTEN PHARMACEUTICAL CO.,LTD. - Filing #7254751

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
Notes - Segment information
Segment information
Revenue
Revenue
300,004,000,000 JPY
301,965,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-685,000,000 JPY
-7,575,000,000 JPY
Profit (loss) before tax
47,481,000,000 JPY
29,874,000,000 JPY
Assets
409,277,000,000 JPY
435,699,000,000 JPY
Investments accounted for using equity method
JPY
2,574,000,000 JPY
Impairment losses
1,302,000,000 JPY
7,779,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.